Tag: Lei Zhang
Hanx Biopharmaceuticals set to begin US clinical trial of HX009 in lymphoma
Hanx Biopharmaceuticals (HanxBio) has obtained approval from the US Food and Drug Administration (FDA) for its investigational new drug (IND) of HX009, enabling the company ... Read More
Cheche Technology to go public through merger with Prime Impact Acquisition I
Chinese auto insurance technology platform Cheche Technology will merge with Prime Impact Acquisition I, a special purpose acquisition company (SPAC), to become a publicly listed ... Read More
Denovo Biopharma gets FDA approval to launch phase 2b GBM trial for DB102
Denovo Biopharma has secured approval from the US Food and Drug Administration (FDA) to launch its phase 2b clinical trial of DB102 in patients with ... Read More